Related Experiment Video
Updated: Jul 13, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Pulmonary alveolar microlithiasis in a patient with rheumatic valvular heart disease
Fotis Sampsonas1, Kiriakos Karkoulias, Alexandros Kaparianos
1Department of Internal Medicine, Division of Pneumology, University Hospital of Rio--Patras, Patras, Greece.
Abstract:
Pulmonary alveolar microlithiasis is a rare disease characterized by widespread intra-alveolar calcification of both lungs that is asymptomatic in the early stages. The disease typically follows a protracted course, and death can occur in 5 to 41 years after the initial diagnosis. Rheumatic fever is a multisystemic inflammatory disease that afflicts the child and juvenile population, and it is still very common in developing countries. Valve failure is the condition most linked to increased morbidity and mortality rates in this population and is the most severe complication of rheumatic fever, with consequent onset of chronic heart valve disease. We present a case of a female patient with a potential diagnosis of pulmonary alveolar microlithiasis with concurrent rheumatic valvular disease.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Mitral Stenosis I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management

